Diagnosing ocular lymphoma can be a challenging process, often requiring multiple tests and examinations because this rare eye cancer can mimic common inflammatory eye conditions. Understanding when to seek diagnostic evaluation and what tests are involved can help ensure earlier detection and proper treatment.

Introduction: Who Should Seek Diagnostic Testing

If you experience certain eye symptoms that persist or worsen, it may be time to see an eye specialist for diagnostic evaluation. Ocular lymphoma, a rare cancer affecting the eye, can develop in anyone, but certain groups are at higher risk and should be particularly attentive to warning signs.^[1]

People with advanced age are more likely to develop ocular lymphoma, as this condition typically affects middle-aged and older individuals. Those with weakened immune systems face elevated risk as well. This includes people living with conditions like AIDS (acquired immunodeficiency syndrome), rheumatoid arthritis, or those taking medications that suppress the immune system, such as anti-rejection drugs following organ transplantation.^[1][3]

The symptoms that should prompt you to seek medical attention include blurry vision, decreased vision or vision loss, and seeing floaters—those small dots or lines that appear to drift across your field of vision. Some people also experience eye redness or swelling, increased sensitivity to light, or in rare cases, eye pain. Because lymphoma usually affects both eyes, you might notice symptoms more obviously in one eye than the other.^[1][5]

When ocular lymphoma affects the central nervous system simultaneously, additional symptoms may appear beyond the eyes. These can include behavioral and cognitive changes, seizures, or other neurological signs. If you experience vision problems alongside any changes in thinking, memory, or behavior, it’s especially important to seek medical evaluation promptly.^[5]

Classic Diagnostic Methods

Diagnosing ocular lymphoma requires a systematic approach because the disease can present in many different ways and closely resembles other, more common eye conditions. The diagnostic journey typically begins with a thorough assessment of your symptoms and medical history, followed by various examinations and tests.^[8]

Initial Eye Examination

When you visit an ophthalmologist with concerning symptoms, the first step is a comprehensive eye examination. Your doctor will check your vision and eye movement carefully. They will use an instrument called an ophthalmoscope, which has a light and a small magnifying lens, to examine the inside of your eye in detail. This allows them to see structures like the retina (the light-sensitive tissue lining the back of your eye), the vitreous (the jelly-like fluid filling the eye), and the optic nerve.^[1]

During this examination, doctors look for specific signs that might suggest lymphoma. Common findings include what appears to be inflammation in the vitreous, which shows up as large individual cells and haziness. About half of patients show obvious yellow deposits underneath the retina. The retinal pigment epithelium, a layer of cells at the back of the eye, often displays changes in pigmentation. Some patients develop solid detachments of this layer due to infiltration by lymphoma cells.^[14]

One characteristic finding in ocular lymphoma is called “leopard spotting”—yellow deposits beneath the retina that create a spotted pattern. However, not everyone with ocular lymphoma will have this finding, and the disease can show many different appearances, which is part of what makes it so challenging to diagnose.^[8]

Advanced Imaging Tests

Beyond the basic eye examination, several imaging technologies help doctors visualize the structures inside your eye more clearly and identify abnormalities that might indicate lymphoma.^[11]

Optical coherence tomography (OCT) is a non-invasive imaging test that creates detailed cross-sectional images of the retina. In most eyes with ocular lymphoma, OCT can reveal focal nodular projections from the retinal pigment epithelium or infiltrates beneath this layer. This imaging helps doctors see the extent and location of abnormal tissue.^[14]

Fluorescein angiography is another imaging technique where a special dye is injected into a vein in your arm, and photographs are taken as the dye travels through the blood vessels in your eye. In ocular lymphoma, this test may reveal focal lesions that appear darker (hypofluorescent) on the images. The test helps distinguish lymphoma from other conditions affecting the blood vessels in the eye.^[14]

Tissue Sampling and Laboratory Analysis

While examinations and imaging can raise suspicion of ocular lymphoma, definitive diagnosis requires obtaining actual cells from inside your eye for laboratory examination. This is the most critical—and most challenging—part of diagnosing ocular lymphoma.^[9]

The standard method for obtaining cells is a procedure called vitrectomy biopsy. During this procedure, a small sample of the vitreous fluid is removed from your eye for examination. An ocular oncologist, a specialist in eye cancers, typically performs this procedure. They can differentiate between the various types of lymphomas that can affect different parts of the eye and ensure proper testing and treatment are arranged.^[1]

Once cells are obtained, they undergo several types of laboratory analysis. Traditional examination under a microscope by a pathologist remains essential, as they look for the characteristic appearance of lymphoma cells. However, additional sophisticated tests have made diagnosis more accurate in recent years.^[2]

Immunohistochemistry is a technique that uses antibodies to identify specific proteins on the surface of cells. Most primary intraocular lymphomas are B-cell lymphomas, meaning they arise from a type of white blood cell called B-lymphocytes. These cells typically show a marker called CD20 on their surface, which helps confirm the diagnosis and can guide treatment decisions.^[11]

Flow cytometry is another laboratory technique that analyzes the characteristics of cells in a fluid sample. It can identify the type of lymphocyte involved and help distinguish lymphoma cells from normal inflammatory cells.^[9]

Molecular analysis has become increasingly important in diagnosing ocular lymphoma. Scientists have discovered that about 80 percent of cases have a specific genetic mutation called MYD88 L265P. A polymerase chain reaction (PCR) test can detect this mutation, which is very helpful because ocular lymphoma has historically been extremely difficult to diagnose. This test has made the diagnostic process somewhat easier and more reliable.^[11]

Analysis of Fluid from the Eye

Beyond examining cells, doctors can also analyze the fluid from your eye to look for markers of lymphoma. One particularly useful marker is the level of a protein called interleukin-10 (IL-10) in the vitreous or aqueous fluid (the clear fluid in the front part of your eye). People with ocular lymphoma typically have elevated levels of IL-10. When compared with another protein called interleukin-6 (IL-6), this ratio can help distinguish lymphoma from inflammatory conditions. High IL-10 levels are also useful for monitoring whether the disease returns after treatment.^[11]

Evaluating for Central Nervous System Involvement

Because ocular lymphoma is closely related to lymphoma of the brain and spinal cord—collectively called the central nervous system—doctors need to evaluate whether the disease has spread beyond the eyes. About 80 percent of people with primary intraocular lymphoma develop it in both eyes, and the disease may also be found in the brain either at the time of diagnosis or later.^[1]

A lumbar puncture, also called a spinal tap, may be performed to obtain cerebrospinal fluid—the fluid that surrounds the brain and spinal cord. This fluid can be examined for lymphoma cells. Brain imaging with magnetic resonance imaging (MRI) scans helps visualize whether lymphoma has spread to the brain. Your care team will work with specialists including neuro-oncologists (doctors who specialize in brain cancers) to ensure comprehensive evaluation.^[1][8]

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for ocular lymphoma treatment, you will likely need to undergo specific diagnostic tests as part of the enrollment process. Clinical trials have standardized criteria to ensure that participants truly have the condition being studied and to establish baseline measurements that can be compared after treatment.^[8]

The standard diagnostic criteria for enrolling in ocular lymphoma clinical trials typically require confirmed diagnosis through tissue biopsy. This means you must have had cells obtained from your eye through vitrectomy or another sampling method, and these cells must have been examined by a pathologist who confirmed the presence of lymphoma. Some trials may also require specific immunohistochemistry results showing that the lymphoma is of B-cell origin with CD20-positive cells.^[11]

Most clinical trials also require brain imaging, usually with MRI scans, to document whether lymphoma has spread to the central nervous system. This information is crucial because it affects treatment approaches and helps researchers understand how treatments work for different stages of disease. Some trials specifically enroll patients with lymphoma only in the eyes, while others may include those with both ocular and central nervous system involvement.^[8]

Baseline vision testing is another standard requirement for clinical trial qualification. Detailed measurements of your visual acuity (how clearly you can see) in each eye, as well as comprehensive eye examinations documenting the extent of disease within each eye, provide important starting points. Researchers use these measurements to determine whether treatments improve, stabilize, or fail to control the disease. Optical coherence tomography scans may be required to document the baseline appearance of your retina and to track changes over time.^[11]

Blood tests measuring IL-10 levels and other markers may be collected at baseline before treatment begins. Some trials examine whether changes in these markers during treatment predict how well the treatment is working. This approach helps researchers identify new ways to monitor disease activity without always needing to perform invasive biopsies.^[11]

General health assessments are also part of clinical trial qualification. Blood tests to check your kidney and liver function, blood counts, and overall health status help ensure that you can safely receive the treatments being studied. Some investigational treatments may not be appropriate for people with certain other health conditions, so these screening tests protect your safety.^[9]

If you developed ocular lymphoma after having systemic lymphoma elsewhere in your body, trials may require additional testing to document the extent of disease throughout your body. This could include CT scans of your chest, abdomen, and pelvis, or PET scans that show areas of active lymphoma. These imaging studies help classify your lymphoma as primary (starting in the eye) or secondary (spreading to the eye from elsewhere), which affects treatment decisions and trial eligibility.^[8]

Clinical trial participation often involves repeat testing at specific intervals throughout the study. After enrollment, you may need periodic vitrectomy biopsies, imaging scans, vision testing, and blood tests to monitor how the disease responds to treatment. While this may seem demanding, these careful measurements are essential for determining whether new treatments are effective and safe. The knowledge gained from clinical trials ultimately helps improve care for future patients with ocular lymphoma.^[11]